Torrent Pharma completes open offer for J.B. Chemicals, boosts stake
Torrent Pharmaceuticals Limited (Acquirer) successfully concluded its open offer for J.B. Chemicals & Pharmaceuticals Limited (Target Company), acquiring 1,317 equity shares at a price of INR 1,639.18/- per share. The total consideration for the acquired shares amounted to INR 21,58,800.06/-. This followed an initial proposal to acquire up to 4,17,45,264 equity shares, representing 26.00% of the Expanded Share Capital, for an aggregate consideration of INR 6,842,80,01,844/-.
The open offer, managed by NovaaOne Capital Private Limited, saw its payment of consideration date on December 5, 2025, after opening on November 18, 2025, and closing on December 1, 2025. Post-offer, Torrent Pharmaceuticals' shareholding in J.B. Chemicals & Pharmaceuticals is 7,83,57,892 equity shares, representing 48.80% of the Expanded Share Capital, while the public shareholding stands at 8,20,40,369 equity shares, or 51.10%.
The Post Offer Advertisement was published on December 8, 2025, in The Financial Express (English National Daily), Jansatta (Hindi National Daily), and Navshakti (Marathi Daily).
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when J.B. Chemicals & Pharmaceuticals publishes news
Free account required • Unsubscribe anytime